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1. INTRODUCTION {#cam42048-sec-0001}
===============

Human papillomavirus (HPV) is the most common sexually transmitted disease in the world.[1](#cam42048-bib-0001){ref-type="ref"} The persistent infection with high‐risk HPV causes Cervical Cancer (CC).[2](#cam42048-bib-0002){ref-type="ref"} In female population it is the fourth cancer and the second most common from 25 to 40 years of age.[3](#cam42048-bib-0003){ref-type="ref"} Strategies against HPV infection are vaccination and safe sex education.[4](#cam42048-bib-0004){ref-type="ref"} Countries that have performed HPV‐vaccination programs have showed a decrease in the prevalence in the population of the HPV 16, 18 genotypes.[5](#cam42048-bib-0005){ref-type="ref"} HPV‐related disease incidence and mortality are the most common measures used to evaluate the impact of vaccination in European Countries.[6](#cam42048-bib-0006){ref-type="ref"} In Europe, HPV‐vaccination coverage rates vary from 30% to 80% with school‐based programs.[7](#cam42048-bib-0007){ref-type="ref"} Information campaigns of health interventions are closely linked to the success of a vaccination program. In fact, the greater the vaccination coverage, the greater will be the efficacy of the program for the prevention of CC and other HPV‐related diseases.[8](#cam42048-bib-0008){ref-type="ref"} In 2006, the European Medicines Agency (EMA) endorsed the quadrivalent HPV vaccine, in 2007 the bivalent, while in June 2015 a 9‐valent vaccine was recommended.[9](#cam42048-bib-0009){ref-type="ref"}

It is important to underline that the two primary (HPV vaccination) and secondary strategies (screening, early diagnosis) will lead to the reduction of incidence and mortality for CC.[10](#cam42048-bib-0010){ref-type="ref"} Relatively to Europe, with regard to CC, vaccination and screening programs show differences among Countries; indeed, relatively to screening, there are organized and nonorganized (opportunistic) programs.[11](#cam42048-bib-0011){ref-type="ref"} Knowledge of the onset of CC, new technologies, HPV test as primary screening test[11](#cam42048-bib-0011){ref-type="ref"} along with home self‐sampling[12](#cam42048-bib-0012){ref-type="ref"}, [13](#cam42048-bib-0013){ref-type="ref"}, [14](#cam42048-bib-0014){ref-type="ref"} modified screening programs in many European Countries.[15](#cam42048-bib-0015){ref-type="ref"}

Cervical cancer screening programs together with primary prevention could contribute to reducing social inequalities between central and eastern European Countries.[16](#cam42048-bib-0016){ref-type="ref"}

The aim of the study was to describe the differences in HPV‐vaccination coverage and screening programs in WHO European Countries notably according to income levels.

2. MATERIALS AND METHODS {#cam42048-sec-0002}
========================

2.1. Gross national income (GNI) {#cam42048-sec-0003}
--------------------------------

According to the World Bank, economies can be divided into low income (LI), lower‐middle income (LMI), upper‐middle income (UMI), and high income (HI) in relation to GNI per capita[17](#cam42048-bib-0017){ref-type="ref"} (Figure [1](#cam42048-fig-0001){ref-type="fig"}). In this study, the 53 WHO ER Countries were thus divided into: LMI, \$1026‐4035 (Armenia, Georgia, Kyrgyzstan, Moldova, Tajikistan, Ukraine, and Uzbekistan); UMI, \$4036‐12 475 (Albania, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Kazakhstan, FYR of Macedonia \[FM\], Hungary, Montenegro, Romania, Serbia, Turkey, and Turkmenistan); and HI, \$12 476 (Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Norway, Poland, Portugal, Slovakia Republic, Slovenia, Spain, Sweden, Switzerland, the Netherlands, and the United Kingdom, Andorra, Croatia, Cyprus, Malta, Monaco, Latvia, Lithuania, Russian Federation, and San Marino) (World Bank and Lending Groups 2016) (Table [1](#cam42048-tbl-0001){ref-type="table"}).[18](#cam42048-bib-0018){ref-type="ref"}, [19](#cam42048-bib-0019){ref-type="ref"}, [20](#cam42048-bib-0020){ref-type="ref"}, [21](#cam42048-bib-0021){ref-type="ref"}, [22](#cam42048-bib-0022){ref-type="ref"}, [23](#cam42048-bib-0023){ref-type="ref"}, [24](#cam42048-bib-0024){ref-type="ref"}, [25](#cam42048-bib-0025){ref-type="ref"}, [26](#cam42048-bib-0026){ref-type="ref"}, [27](#cam42048-bib-0027){ref-type="ref"}, [28](#cam42048-bib-0028){ref-type="ref"}, [29](#cam42048-bib-0029){ref-type="ref"}, [30](#cam42048-bib-0030){ref-type="ref"}, [31](#cam42048-bib-0031){ref-type="ref"}, [32](#cam42048-bib-0032){ref-type="ref"}, [33](#cam42048-bib-0033){ref-type="ref"}, [34](#cam42048-bib-0034){ref-type="ref"}, [35](#cam42048-bib-0035){ref-type="ref"}, [36](#cam42048-bib-0036){ref-type="ref"}, [37](#cam42048-bib-0037){ref-type="ref"}

![Map of Countries grouped according to income levels](CAM4-8-2524-g001){#cam42048-fig-0001}

###### 

Differences of CC burden, primary and secondary prevention programs in 53 Countries of the WHO Region

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                         National immunization   Cancer screening                                                                                                                                                                                                                                                                                                                                                                        
  ------------------------------- ----------------------- ------------------ ----------------------- ------------------------------------------------------------------------------ -------------------------------------------- -------------------------------------------- ----------------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------
  Austria                         5.7\                    2.2\               2014\                   Fully covered by patient\                                                      Opportunistic 1970                           National\                                    Cytology PAP                                                \>18                                                1                                                   Free of Charge
                                  5.8                     2.6                9‐12                    NR                                                                                                                          86.6 (2014)                                                                                                                                                                                                      

  Andorra                         NR\                     NR\                2014\                   NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                \>18                                                1                                                   NR
                                  NR                      NR                 12                      NR                                                                                                                          61.4 (2011)                                                                                                                                                                                                      

  Belgium                         8.4\                    2.5\               2007\                   75% supported by national health authorities\                                  Opportunistic 1965\                          Regional\                                    Cytology PAP                                                25‐64                                               3                                                   Free of Charge
                                  8.6                     2.3                12                      NR                                                                             Organized 1994                               68.7 (2013)                                                                                                                                                                                                      

  Croatia                         11.8\                   4.2\               2016\                   Fully covered by national health authorities^23^\                              Opportunistic 1960\                          National\                                    Cytology PAP[a](#hsc12715-note-0002){ref-type="fn"}         25‐64                                               3                                                   Free of Charge
                                  10.0                    3.4                NR                      NR                                                                             Organized 2012                               65.3 (2003)                                                                                                                                                                                                      

  Cyprus                          4.5\                    2.6\               2016\                   NR\                                                                            Opportunistic\                               NR\                                          Cytology PAP                                                24‐65                                               NR                                                  NR
                                  4.1                     1.3                11‐12                   NR                                                                             NR                                           67.4 (2012)                                                                                                                                                                                                      

  Czech Republic                  14.0\                   4.6\               2012\                   Covered by general health insurance for routine\                               Opportunistic 1947\                          National\                                    Cytology PAP                                                25‐60                                               1                                                   Free of Charge
                                  14.1                    4.8                13                      81.0 (2011)                                                                    Organized 2008                               87.2 *(*2014*)*                                                                                                                                                                                                  

  Denmark                         12.1\                   3.1\               2009\                   Fully covered by national health authorities\                                  Opportunistic 1962\                          National policy, local implementation\       HPV\                                                        60‐64 HPV[b](#hsc12715-note-0003){ref-type="fn"}\   5 (60‐64) HPV\                                      Free of Charge
                                  10.6                    2.6                12                      79.0 (2011)                                                                    Organized 2006                               64.1 *(*2014*)*                              Cytology PAP^12^                                            23‐59 Cytol.                                        3 (23‐59) Cytology                                  

  Estonia                         15.8\                   7.3\               No program              ‐                                                                              Organized 2006                               National\                                    Cytology PAP^12^                                            30‐59                                               5                                                   Free of Charge
                                  19.9                    7.5                                                                                                                                                                    57.7 *(*2014*)*                                                                                                                                                                                                  

  Finland                         4.5\                    1.5\               2013\                   Fully covered by national health authorities\                                  Organized 1963                               National\                                    HPV\                                                        30‐64                                               5[c](#hsc12715-note-0004){ref-type="fn"}            Free of Charge
                                  4.3                     1.3                11‐12                   29.3 (2012)                                                                                                                 69.0 *(*2015*)*                              Cytology PAP^12^                                                                                                                                                    

  France                          7.1\                    1.9\               2007\                   65% supported by national health authorities\                                  Organized\                                   Regional^12^\                                Cytology PAP                                                25‐65                                               3                                                   Insurance\
                                  6.8                     1.8                11‐14                   24.0 (2008)                                                                    1991                                         75.4 (2014)                                                                                                                                                                                                      Copayment

  Germany                         6.9\                    2.6\               2007\                   Fully covered by national health authorities\                                  Organized 1971 (west)\                       National\                                    Cytology PAP                                                ≥20                                                 1                                                   Free of Charge
                                  8.2                     2.6                9‐14                    NR                                                                             1991 (expanded to the eastern country)^17^   80.4 (2014)                                                                                                                                                                                                      

  Greece                          4.1\                    1.4\               2008\                   Fully covered by national health authorities\                                  Opportunistic 1991                           National\                                    Cytology PAP                                                ≥20                                                 1                                                   NR
                                  5.2                     1.9                11‐15                   NR                                                                                                                          75.5 (2014)                                                                                                                                                                                                      

  Hungary                         16.6\                   6.6\               2014\                   NR\                                                                            Opportunistic 1950\                          National\                                    Cytology PAP                                                25‐65                                               3                                                   Free of Charge
                                  18.0                    6.2                NR                      88.0 (2014)                                                                    Organized 2003                               40.1 (2015)                                                                                                                                                                                                      

  Iceland                         8.4\                    0.8\               2011\                   Fully covered by national health authorities\                                  Organized 1964^20^                           National\                                    Cytology PAP^12^                                            20*‐*69                                             2 (20‐39)\                                          NR
                                  7.9                     1.9                12                      84.0 (2013)                                                                                                                 71.0 (2015)                                                                                                                                                  4 (40‐69)                                           

  Ireland                         10.9\                   3.6\               2010\                   Fully covered by national health authorities\                                  Organized 2008                               National\                                    Cytology PAP                                                25‐60                                               3 (25‐44)\                                          Free of Charge
                                  13.6                    4.0                12‐13                   84.9 (2014)                                                                                                                 78.7 (2015)                                                                                                                                                  5 (45‐60)                                           

  Israel\                         NR\                     2.4\               2013\                   NR\                                                                            Opportunistic\                               Regional\                                    Cytology PAP                                                25‐65^21^                                           3                                                   Free of Charge^31^
  Outside European institutions   4.6                     2.0                13                      80.0 (2011)                                                                    NR                                           32.0 (2008)                                                                                                                                                                                                      

  Italy                           6.7\                    0.8\               2007\                   Fully covered by national health authorities\                                  Organized 1996                               National policy, local implementation^14^\   HPV\                                                        25‐64                                               5 HPV\                                              Free of Charge
                                  6.7                     0.9                12                      65.0 (2011)                                                                                                                 79.0 *(*2015*)*                              Cytology PAP                                                                                                    3 Cytology                                          

  Latvia                          12.4\                   6.9\               2010\                   Fully covered by national health authorities\                                  Opportunistic 1960\                          National\                                    Cytology PAP^18,^ [d](#hsc12715-note-0005){ref-type="fn"}   25‐70                                               3                                                   Free of Charge
                                  17.3                    8.5                12                      NR                                                                             Organized 2009                               25.2 (2016)                                                                                                                                                                                                      

  Lithuania                       21.0\                   10.6\              2016\                   NR\                                                                            Organized 2004                               National\                                    Cytology PAP                                                25‐60                                               3                                                   Free of Charge
                                  26.1                    9.0                NR                      29.0 (2009)                                                                                                                 74.0 (2014)                                                                                                                                                                                                      

  Luxembourg                      6.3\                    5.6\               2008\                   Fully covered by national health authorities\                                  Opportunistic 1962\                          National\                                    Cytology PAP                                                \>15                                                1                                                   NR
                                  4.9                     1.7                12‐18                   17.0 (2009)                                                                    Organized 1990                               83.6 (2014)                                                                                                                                                                                                      

  Malta                           2.1\                    2.1\               2012\                   Fully covered by national health authorities\                                  Opportunistic\                               National\                                    HPV\                                                        \>30 HPV\                                           5 HPV\                                              Free of Charge
                                  3.8                     2.4                12                      NR                                                                             NR                                           49.3 (2008)                                  Cytology PAP                                                25‐50 Cytol.                                        3 Cytology[e](#hsc12715-note-0006){ref-type="fn"}   

  Monaco                          NR\                     NR\                2011\                   NR\                                                                            Opportunistic\                               NR\                                          Cytology PAP                                                21‐65                                               1[f](#hsc12715-note-0007){ref-type="fn"}            NR
                                  NR                      NR                 14                      NR                                                                             NR                                           NR                                                                                                                                                                                                               

  Norway                          9.4\                    3.0\               2009\                   Fully covered by national health authorities\                                  Opportunistic 1970^12^\                      National\                                    Cytology PAP^12,^ [g](#hsc12715-note-0008){ref-type="fn"}   25‐69                                               3                                                   NR
                                  9.8                     2.1                12                      63.0 (2011)                                                                    Organized 1995^12^                           74.1 (2015)                                                                                                                                                                                                      

  Poland                          11.6\                   7.3\               No Program              ‐\                                                                             Opportunistic 1970\                          National\                                    Cytology PAP                                                25‐59                                               3                                                   Free of Charge
                                  12.2                    6.7                                        *‐*                                                                            Organized 2006                               21.2 (2013)                                                                                                                                                                                                      

  Portugal                        12.2\                   3.4\               2008\                   Fully covered by national health authorities\                                  Organized Central Region 1990\               Regional\                                    Cytology PAP                                                25‐64                                               3                                                   Free of Charge
                                  9.0                     2.8                13                      84.0 (2011)                                                                    Alentejo Region 2008                         70.7 (2014)                                                                                                                                                                                                      

  Russian Federation\             13.3\                   6.6\               Partial program 2009\   NR\                                                                            Organized\                                   NR\                                          Cytology PAP                                                \>18                                                1                                                   NR
  Outside European institutions   15.3                    6.9                12‐13                   NR                                                                             NR                                           72.0 (2012)                                                                                                                                                                                                      

  San Marino                      NR\                     NR\                2008\                   Fully covered by national health authorities\                                  Opportunistic 1968\                          National\                                    HPV\                                                        30‐65 HPV\                                          5 HPV\                                              NR
                                  NR                      NR                 11‐14                   NR                                                                             Organized 2006^33^                           82.0 *(*2017*)* ^19^                         Cytology PAP                                                25‐30 Cytol.                                        3 Cytology                                          

  Slovakia Republic               15.8\                   6.5\               2014\                   NR\                                                                            Opportunistic 1980\                          National\                                    Cytology PAP                                                23‐64                                               1                                                   Free of Charge
                                  16.1                    6.9                12                      55.0 (2012)                                                                    Organized 2008                               69.0 (2014)                                                                                                                                                                                                      

  Slovenia                        11.1\                   3.1\               2009\                   Fully covered by national health authorities\                                  Opportunistic 1960\                          National\                                    Cytology PAP                                                20‐64                                               3                                                   Free of Charge
                                  10.5                    2.9                11                      70.8 (2012)                                                                    Organized 2003                               71.9 (2016)                                                                                                                                                                                                      

  Spain                           6.3\                    2.1\               2007\                   Fully covered by national health authorities\                                  Organized 1993                               National^18^\                                HPV\                                                        30‐65 HPV\                                          5 HPV\                                              Free of Charge
                                  7.8                     2.1                11‐14                   78.5 (2010)                                                                                                                 72.7 (2014)                                  Cytology PAP                                                25‐65 Cytol.                                        3 Cytology                                          

  Sweden\                         7.8\                    2.2\               2010\                   Fully covered by national health authorities\                                  Opportunistic 1950\                          National\                                    HPV\                                                        30‐64 HPV\                                          3 (30‐50)\                                          Free of Charge
  4,100,000                       7.4                     2.8                10‐12                   82.0 (2012)^24^                                                                Organized 1967                               81.7 (2015)                                  Cytol. PAP^12,^ [h](#hsc12715-note-0009){ref-type="fn"}     23‐29 Cytol.^12^                                    7 (51‐64) HPV.\                                     
                                                                                                                                                                                                                                                                                                                                                                                              3 (23‐29) Cytology                                  

  Switzerland                     4.0\                    1.4\               2008\                   NR\                                                                            Opportunistic\                               NR\                                          Cytology PAP                                                \>20                                                3                                                   Insurance\
                                  3.6                     1.5                11‐14                   NR                                                                             NR                                           74.5 (2012)                                                                                                                                                                                                      Copayment

  Netherlands                     6.8\                    2.3\               2010\                   Fully covered by national health authorities\                                  Opportunistic 1970\                          National\                                    HPV[i](#hsc12715-note-0010){ref-type="fn"}\                 30‐60                                               5 HPV\                                              Free of Charge
                                  6.8                     1.9                12                      79.5 (2014)                                                                    Organized 1980                               64.4 (2015)                                  Cytology PAP                                                                                                    5 Cytology                                          

  United Kingdom                  7.2\                    2.4\               2008\                   Fully covered by national health authorities\                                  Opportunistic 1964\                          National\                                    Cytology PAP[j](#hsc12715-note-0011){ref-type="fn"}         25‐64                                               3 (25‐49);\                                         Free of Charge
                                  7.1                     2.2                12‐13                   91.4 (2013)                                                                    Organized 1988                               77.5 (2016)                                                                                                                                                  5 (50‐64)                                           

  Albania                         7.1\                    1.5\               No Program              NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                \>20                                                2‐3                                                 NR
                                  5.0                     1.8^3^                                     NR                                                                                                                          2.7 (2002)                                                                                                                                                                                                       

  Azerbaijan\                     NR\                     NR\                No Program              NR\                                                                            No Program                                   1.1 (2001)                                   Acetic acid visualization VIA                               NR                                                  ‐                                                   NR
  Outside European institutions   9.8                     3.9^3^                                     NR                                                                                                                                                                                                                                                                                                                                           

  Belarus\                        13.2\                   6.2\               No Program              NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                \>18                                                1                                                   NR
  Outside European institutions   13.2                    4.7^3^                                     NR                                                                                                                          75 (2015)                                                                                                                                                                                                        

  Bosnia and Herzegovina          9.1\                    NR\                No Program              NR\                                                                            Organized\                                   National\                                    Cytology PAP                                                21‐70                                               1                                                   NR
                                  13.7                    2.7                                        NR                                                                             NR                                           39.8 (2003)                                                                                                                                                                                                      

  Bulgaria                        21.9\                   7.0\               2012\                   Covered by general health; catch‐up is opportunistic and not free of charge\   Opportunistic NR                             NR\                                          Cytology PAP                                                30‐59                                               3                                                   NR
                                  24.5                    7.8                12                      NR                                                                                                                          46.8 (2008)                                                                                                                                                                                                      

  Kazakhstan\                     NR\                     8.8\               Partial program\        NR\                                                                            Organized\                                   National\                                    Cytology PAP                                                30‐60                                               5                                                   NR
  Outside European institutions   29.4                    9.1                2013\                   NR                                                                             NR                                           80.3 (2003)                                                                                                                                                                                                      
                                                                             11                                                                                                                                                                                                                                                                                                                                                                   

  FRY of Macedonia                22.0\                   4.1\               2009\                   NR\                                                                            Organized 2015                               National\                                    Cytology PAP                                                30‐55                                               3                                                   NR
                                  12.4                    3.5                12                      NR                                                                                                                          60.0 (2015)                                                                                                                                                                                                      

  Montenegro                      13.0\                   5.2\               No Program              NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                25‐64                                               3                                                   NR
                                  20.2                    5.8^3^                                     NR                                                                                                                          NR                                                                                                                                                                                                               

  Romania                         23.9\                   13.7\              2008\                   Fully covered by national health authorities\                                  Opportunistic 1965\                          National\                                    Cytology PAP                                                25‐64                                               5                                                   Free of Charge
                                  28.6                    12.0               12‐14                   NR                                                                             Organized 2012                               8.1 (2014)                                                                                                                                                                                                       

  Serbia                          20.9\                   10.3\              2017^21^\               NR\                                                                            Opportunistic\                               National\                                    Cytology PAP                                                25‐65                                               3                                                   Free of Charge
                                  23.8                    9.3                12                      NR                                                                             1960\                                        57.1 (2013)                                                                                                                                                                                                      
                                                                                                                                                                                    Organized\                                                                                                                                                                                                                                                    
                                                                                                                                                                                    2011^22^                                                                                                                                                                                                                                                      

  Turkey                          NR\                     NR\                No Program              NR\                                                                            Opportunistic\                               National\                                    HPV^23,^ [k](#hsc12715-note-0012){ref-type="fn"}            30‐65                                               5                                                   NR
                                  4.3                     1.7                                        NR                                                                             1985\                                        46.5 (2015)                                                                                                                                                                                                      
                                                                                                                                                                                    Organized\                                                                                                                                                                                                                                                    
                                                                                                                                                                                    2004^23^                                                                                                                                                                                                                                                      

  Turkmenistan\                   NR\                     5.9\               2016\                   NR\                                                                            Opportunistic\                               National\                                    Cytology PAP                                                \>20                                                1                                                   NR
  Outside European institutions   13.1                    10.1               9                       NR                                                                             NR                                           NR                                                                                                                                                                                                               

  Armenia                         NR\                     3.7\               No Program              NR\                                                                            Opportunistic\                               NR\                                          Cytology PAP                                                30‐60                                               3                                                   NR
                                  13.8                    5.5                                        NR                                                                             NR                                           9.3 (2010)                                                                                                                                                                                                       

  Georgia\                        NR\                     NR\                NR                      NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP[l](#hsc12715-note-0013){ref-type="fn"}         25‐60                                               3                                                   Free of Charge
  EU19                            14.2                    5.7                                        36.2 (2012)                                                                                                                 9.0 (2011)                                                                                                                                                                                                       

  Kyrgyzstan\                     NR\                     12.6\              No Program              NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                NR                                                  5                                                   NR
  Outside European institutions   23.7                    11.4                                       53.4                                                                                                                        10‐50 (2015)                                                                                                                                                                                                     

  Republic of Moldova             17.1\                   8.6\               NR                      NR\                                                                            Organized\                                   National\                                    Cytology PAP                                                \>20                                                2                                                   NR
                                  19.6                    7.5                                        NR                                                                             NR                                           70.0 (2015)                                                                                                                                                                                                      

  Tajikistan\                     NR\                     NR\                NR                      NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                \>20                                                NR                                                  NR
  Outside European institutions   9.9                     4.9                                        65.0 (2012)                                                                                                                 10‐50 (2015)                                                                                                                                                                                                     

  Ukraine                         NR\                     7.4\               No Program              NR\                                                                            Opportunistic\                               NR\                                          Cytology PAP                                                18‐65                                               1                                                   NR
                                  16.6                    7.5                                        86.7 (2014)                                                                    NR                                           73.7 (2003)                                                                                                                                                                                                      

  Uzbekistan\                     NR\                     NR\                Announced\              NR\                                                                            Opportunistic NR                             NR\                                          Cytology PAP                                                25‐49                                               NR                                                  NR
  Outside European institutions   13.5                    6.4                12                      NR                                                                                                                          NR                                                                                                                                                                                                               
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

R: Not Reported.

Acetic acid visualization VIA HPV secondary test as a triage to borderline cytology and as a follow‐up after treatment of severe cervical lesions.

Interval between negative screens is three years for women aged 23‐49 and five years for women aged 50‐64. The primary screening test is cytology for women aged 23‐59 with HPV as a triage test. HPV DNA test is primary screening for women aged 60‐64 years.

Primary screening test is predominantly cytology but can also be HPV. The sample is examined for cell changes (the traditional Pap test) or the Human Papillomavirus. If there is cancer‐related HPV, the screening sample is checked for possible cervical cell changes (Pap test).

HPV testing is not reimbursed.

Screening ages: Above 25 (cytology), Above 30 (HPV test). Screening interval: Cytology every 3 years (ages 25‐50), VIA every 5 years (above 50). HPV test every 5 years.

1, 3 after 2 consecutive annual negative Cytology test.

HPV as primary screening test is underway in part of the country for women between 34 and 69 years of age.

Reflex testing with HPV is done for cytology positive test (ASCUS/LSIL or worse) below the age of 30 and reflex testing with cytology for HR HPV positive test above the age of 30. A double test (cytology and HPV) is recommended for women at age 41. Women with HPV positive/cytology negative tests should repeat screening after 3 years. Women with ASCUS/LSIL (regardless of HPV status) below the age of 28 are not referred to colposcopy, but repeat cytology.

Replace Pap‐test with hrHPV DNA test as primary screening test (since 2016).

If slightly abnormal cells are present, the human papillomavirus (HPV) will be tested.

HPV test since 2015.

HPV test undergoing project.

John Wiley & Sons, Ltd

2.2. Sources of WHO European epidemiological data {#cam42048-sec-0004}
-------------------------------------------------

The main data source, the GLOBOCAN 2012 website of the International Agency for Research on Cancer (IARC), provides access to several databases that allow assessing the impact of CC in 184 Countries or territories.[38](#cam42048-bib-0038){ref-type="ref"}

These data were supplemented using the literature, ministerial web site of WHO ER Countries, World Bank Open Data Web site and the World Cancer Registry (X edition).[17](#cam42048-bib-0017){ref-type="ref"}

2.3. Statistical analysis {#cam42048-sec-0005}
-------------------------

Multiple correspondence analysis (MCA) was applied to examine the association among the following variables: GNI levels (LMI, UMI, and HI); type of CC screening program in each country (coverage; opportunistic/organized); vaccination payment policies (free or partial or total charge); mortality rates/100 000 (≤3; \>3‐6; \>6‐9; \>9); incidence rates/100 000 (≤7; \>7‐15; \>15‐21; \>21). Data HPV‐vaccination start (years) (2006‐2008; 2009‐2011; 2012‐2014; \>2014; no program); HPV‐vaccination coverage percentage (≤25; 26‐50; 51‐75; \>75); data screening start (years) (\<1960; 1960‐1980; 1981‐2000; \>2000); primary screening test (HPV, cytology); screening coverage percentage (≤25; \>25‐50; \>50‐75; \>75).

These variables were coded as ordinal, nominal or dummy, as appropriate, and incorporated into the model.

3. RESULTS {#cam42048-sec-0006}
==========

3.1. Multiple correspondence analysis {#cam42048-sec-0007}
-------------------------------------

The results of MCA are shown in Figures [2](#cam42048-fig-0002){ref-type="fig"} and [3](#cam42048-fig-0003){ref-type="fig"}. We identified two dimensions that explain 82% of the variance: the first is 49% and the second being 33%.

![Association among variables included in model of multiple correspondence analysis](CAM4-8-2524-g002){#cam42048-fig-0002}

![Distribution of 53 European Countries according to multiple correspondence analysis](CAM4-8-2524-g003){#cam42048-fig-0003}

The first quadrant (top right) identified the following variables: an early initiation of vaccination programs based on HPV screening as primary test; a high‐screening coverage and low incidence and mortality rates. In addition, low‐vaccination coverage and different payment policies (free, partial or total charge) for vaccination programs are located in this quadrant. High income, screening before 1960, medium‐high screening coverage, start of vaccination in the periods 2009‐2011 and 2012‐2014, and high‐immunization coverage are in the fourth quadrant (bottom‐right). On the left side, we can see medium‐low and medium‐high income, low attention to primary and secondary prevention with high rates of occurrence. In the second quadrant (top left), instead, we can observe upper‐middle income, total absence of screening and vaccination programs, medium‐low incidence and mortality rates. The third quadrant (bottom left) stands out with lower‐middle income, late start of vaccination programs and screening with cytology as primary test, medium‐high mortality and incidence rates, and medium vaccination coverage (Figure [2](#cam42048-fig-0002){ref-type="fig"}). It is important to highlight that most EU‐28 Countries are mainly located between the first and fourth quadrants with high income. On the contrary, the Countries outside of the EU‐28 are located between the second and third quadrant with upper‐middle income and lower‐middle income (Figure [3](#cam42048-fig-0003){ref-type="fig"}).

4. DISCUSSION {#cam42048-sec-0008}
=============

In 2015, 526.000 women developed CC worldwide and caused 239.000 deaths.[39](#cam42048-bib-0039){ref-type="ref"} The pap‐test screening programs, allowing an early diagnosis of precancerous lesions and a timely treatment of the same, have allowed to reduce the incidence of cervical cancer. Vaccination prevents precancerous lesions, reduces cancer and related treatments to eliminate precancerous lesions. Vaccination, acting much earlier in the history of disease development, prevents chronic infection resulting in pre‐cancerous lesions. Vaccination and screening programs are fundamental because they are potentially cost‐effective and allow decreasing incidence and mortality rates of CC.[40](#cam42048-bib-0040){ref-type="ref"} Screening, however, will remain fundamental for prevention of CC despite HPV vaccines.[41](#cam42048-bib-0041){ref-type="ref"} In fact, a factor that determines the differences in the incidence of CC among Countries is the screening coverage of the population.[7](#cam42048-bib-0007){ref-type="ref"}

Monitoring HPV‐vaccination coverage is important to evaluate the performance of vaccination programs and the potential impact of HPV vaccine on cervical cancer. In fact, cervical cancer screening programs will need to be adjusted to the number of vaccinated people eligible for screening. However, despite the documented effectiveness of HPV vaccine, there is still an incomplete availability to this prevention action in the world population. Bruni et al[42](#cam42048-bib-0042){ref-type="ref"} showed high differences in number of women vaccinated according to gross income level countries; in fact, high‐quality primary and secondary cancer prevention is nearly always available in wealthy countries with gross national income (GNI) level.[42](#cam42048-bib-0042){ref-type="ref"} Moreover, higher income allows access to better resources and living standards and can increase the ability to maintain healthy behaviors.[43](#cam42048-bib-0043){ref-type="ref"} Syse and Lyngstand showed that high income is also related to higher survival rate.[44](#cam42048-bib-0044){ref-type="ref"}

Our study shows that European Countries with higher income have higher screening and immunization coverage probably due to organized screenings starting before 1960 that determined low incidence and mortality rates, respect to those with lower‐middle income. High‐income countries have HPV screening test as the primary test and total or free partial charge HPV vaccination.

Eastern European and Asian Countries have lower‐middle income and show high incidence and mortality rates. These countries have an opportunistic screening with lower‐screening coverage and lower‐immunization coverage probably because HPV vaccine was introduced later. Globally, the coverage of vaccination is higher in countries with high income; by 2016, 71% of HI countries, 35% UMI countries, 8% of LMI countries, and 6% of LI countries had introduced the HPV vaccine.[45](#cam42048-bib-0045){ref-type="ref"}

Only eight of the 70 countries who reported HPV vaccine introduction by the end of 2016, made the vaccine available to boys in addiction to girls (Australia, Austria, Barbados, Brazil, Canada, Italy, Switzerland, and the United States).[46](#cam42048-bib-0046){ref-type="ref"} According to Brisson et al,[47](#cam42048-bib-0047){ref-type="ref"} greater benefits can be acquired for both female and male by increasing HPV‐vaccination coverage among girls. In addition, vaccination of both sexes would be more equitable.[48](#cam42048-bib-0048){ref-type="ref"}

In light of this, we would like to point out that: first, the strategy of including males in vaccination campaigns has, without a doubt, the function of reducing the circulation of the virus (herd‐effect) and the transmission of infection between the two sexes. It has also the advantage of countering the occurrence of HPV‐related diseases affecting male anatomic sites, such as the penis. Second, it is important to stress that both sexes have the same right to benefit from the advantages of anti‐HPV vaccination. In fact, according to European regulations, it is a right of every citizen to take advantage of disease prevention programs, where there is an effective means of prevention like the anti‐HPV vaccine. Third, a universal anti‐HPV vaccination program reduces the prejudices created around a female‐only vaccination, helping to reduce sociocultural barriers and thereby increasing acceptability and vaccination coverage.

Public health authorities should monitor the HPV‐vaccinated population in order to determine more precisely the effects on short‐ and long‐term incidence and mortality rates.

A useful scenario for crucial support to public health decision‐makers is the strength of our paper. On the other hand, a limitation could be that the data that came from low‐income countries must be considered with caution, both because they come from local registries (rather than the population‐based cancer registries used for the other countries) and because the International Classification Disease, 9th revision, codes are not always accurate.
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